Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 6, 1999, Pages 1786-1790

  Nightingale, Julia A ^a   Rogers, Duncan F ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; FORMOTEROL; HISTAMINE; METHACHOLINE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BRONCHODILATING ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MAST CELL; MEDIATOR RELEASE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032992412     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.6.9809090     Document Type: Article

References (25)

1. 1. Nelson, H. S. 1997. β-Adrenergic bronchodilators. N. Engl. J. Med. 333:499-506.
2. 2. British Thoracic Society. 1997. Asthma in adults and schoolchildren. Thorax 52(Suppl. 1):S2-S8.
3. 2 agonists: greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma. Am. J. Respir. Crit. Care Med. 150:381-387.
4. 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5′-monophosphate in asthma. J. Allergy Clin. Immunol. 85:755-762.
5. 5. Rabe, K. F., R. Jorres, D. Nowak, N. Behr, and H. Magnussen. 1993. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am. Rev. Respir. Dis. 147:1436-1441.
6. 2-agonist. J. Allergy Clin. Immunol. 89:844-849.
7. 2-agonists in asthma. N. Engl. J. Med. 327:1204-1208.
8. 8. Cushley, M. J., and S. T. Holgate. 1985. Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release. J. Allergy Clin. Immunol. 75:272-278.
9. 9. Björck, T., L. E. Gustafsson, and S. E. Dahlén. 1992. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am. Rev. Respir. Dis. 145:1087-1091.
10. 10. Taylor, D. A., M. W. Jensen, S. L. Aikman, J. G. Harris, P. J. Barnes, and B. J. O'Connor. 1997. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Am. J. Respir. Crit. Care Med. 156:1731-1737.
11. 11. Solèr, M., L. Joos, C. T. Bolliger, S. Elsasser, and A. P. Perruchoud. 1994. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine and AMP-induced bronchoconstriction. Eur. Respir. J. 7:1973-1977.
12. 12. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
13. 13. Glantz, S. A. 1997. Primer of Biostatistics, 4th ed. McGraw-Hill, New York.
14. 14. Phillips, G. D., P. Rafferty, R. Beasley, and S. T. Holgate. 1987. Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophosphate in non-atopic asthma. Thorax 42:939-945.
15. 15. Rafferty, P., R. Beasley, and S. T. Holgate. 1987. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5′-monophosphate in atopic asthma. Am. Rev. Respir. Dis. 136:369-373.
16. 16. Church, M. K., and J. Hiroi. 1987. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br. J. Pharmacol. 90:421-429.
17. 17. Lau, H. Y., P. L. Wong, C. K. Lai, and J. K. Ho. 1994. Effects of long-acting beta 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human. Int. Arch. Allergy Immunol. 105:177-180.
18. 18. Nials, A. T., D. I. Ball, P. R. Butchers, R. A. Coleman, A. A. Humbles, M. Johnson, and C. J. Vardey. 1994. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. Eur. J. Pharmacol. 251:127-135.
19. 19. Howarth, P. H., S. R. Durham, T. H. Lee, A. B. Kay, M. K. Church, and S. T. Holgate. 1985. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am. Rev. Respir. Dis. 132:986-992.
20. 20. Carlsson, L.-G., E. Arweström, K. Friberg, C. G. Löfdahl, and H. Lunde. 1998. Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible obstruction. Allergy 53:712-715.
21. 21. Ruffin, R. E., J. D. Fitzgerald, and A. S. Rebuck. 1977. A comparison of the bronchodilator activity of Sch 1000 and salbutamol. J. Allergy Clin. Immunol. 59:136-141.
22. 2-agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Thorax 46:9-14.
23. 23. Wong, A. G., A. D. O'Shaughnessy, C. M. Walker, and M. R. Sears. 1997. Effects of long-acting and short-acting β-agonists on methacholine dose-response curves in asthmatics. Eur. Respir. J. 10:330-336.
24. 24. Jeppsson, A.-B., B.-L. Källström, and B. Waldeck. 1992. Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro. Pharmacol. Toxicol. 71:272-277.
25. 25. Rabe, K. F., M. A. Giembycz, R. S. Perkins, P. Evans, and P. J. Barnes. 1993. Salmeterol is a competetive antagonist at beta-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils. Eur. J. Pharmacol. 231:305-308.